MediciNova
MNOV
47 hedge funds and large institutions have $41.3M invested in MediciNova in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
4% more funds holding
Funds holding: 45 → 47 (+2)
0.6% more ownership
Funds ownership: 22.16% → 22.75% (+0.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $45.8M → $41.3M (-$4.49M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$799K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$198K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$182K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$172K |
| 5 |
SG Americas Securities
New York
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$558K |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$129K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$114K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$87K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$55.4K |
MNOV Hedge Fund Activity: Q2 2017 in Review
47 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2017, worth a combined $41.3M — down 9.8% from $45.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MNOV positions and 2 closed out — a net gain of 2 holders — while 16 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $799K. The largest seller was Fidelity Investments, cutting an estimated $558K.
- 47 institutional investors held MediciNova (MNOV) as of Q2 2017, up from 45 in Q1 2017.
- Funds reported $41.3M of MediciNova stock for Q2 2017, down 9.8% quarter-over-quarter.
- 4 funds opened new MediciNova positions in Q2 2017 and 2 closed out, a net change of +2 holders.
- The largest MediciNova buyer in Q2 2017 was BlackRock, an estimated $799K added.
- The largest MediciNova seller in Q2 2017 was Fidelity Investments, an estimated $558K sold.
Based on aggregated 13F filings for Q2 2017.